Results 31 to 40 of about 1,765 (123)

Theratyping as a tool to guide clinical decision-making in patients with suspected cystic fibrosis and variants currently ineligible for CFTR modulator therapy. [PDF]

open access: yesRespir Med
Gannon RM   +10 more
europepmc   +1 more source

Fyn-Saracatinib Complex Structure Reveals an Active State-like Conformation. [PDF]

open access: yesInt J Mol Sci
Ta HM   +5 more
europepmc   +1 more source

Impact of Elexacaftor-Tezacaftor-Ivacaftor on Quality of Life in Children With Cystic Fibrosis. [PDF]

open access: yesPediatr Pulmonol
Kümmerli S   +6 more
europepmc   +1 more source

Piperine protects ovarian follicles and stromal cells against doxorubicin-induced adverse effects in mouse ovaries. [PDF]

open access: yesJBRA Assist Reprod
Rocha MBM   +10 more
europepmc   +1 more source

Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function and fat malabsorption: Report of PROMISE pediatric substudy. [PDF]

open access: yesJ Cyst Fibros
Green N   +14 more
europepmc   +1 more source

Effect of Elexacaftor/Tezacaftor/Ivacaftor Treatment on Extrapulmonary Complications of Cystic Fibrosis. [PDF]

open access: yesAdv Ther
Geiger JM   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy